Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties
Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties
Aclaris Therapeutics宣布与Sun Pharma就Deuruxolitinib的权利达成独家专利许可协议;协议包括1500万美元的预付款,外加里程碑和特许权使用费
Aclaris Therapeutics Announces Exclusive Patent License Agreement With Sun Pharma For Rights Of Deuruxolitinib; Agreement Includes Upfront Payment Of $15M Plus Milestones And Royalties
Aclaris Therapeutics宣布与Sun Pharma就Deuruxolitinib的权利达成独家专利许可协议;协议包括1500万美元的预付款,外加里程碑和特许权使用费